Buprenorphine: Difference between revisions
From Protocopedia
Created page with "==Section 8 - MEDICATION GUIDELINES== ===ANTICONVULSANT=== ====Buprenorphine ==== '''DESCRIPTION / ACTION:''' * Medication to treat opioid use disorder (OUD) '''INDICATIONS:''' * Patients precipitated opioid withdrawal who agree to start recovery and agree to transport to a designated CORE transport facility '''CONTRAINDICATIONS:''' * Severe hypersensitivity, including anaphylaxis and angioedema '''DOSE:''' * 8mg Sublingual Tablet as per Protocol Category:Medication..." |
(No difference)
|
Latest revision as of 19:02, 3 December 2024
Section 8 - MEDICATION GUIDELINES
ANTICONVULSANT
Buprenorphine
DESCRIPTION / ACTION:
- Medication to treat opioid use disorder (OUD)
INDICATIONS:
- Patients precipitated opioid withdrawal who agree to start recovery and agree to transport to a designated CORE transport facility
CONTRAINDICATIONS:
- Severe hypersensitivity, including anaphylaxis and angioedema
DOSE:
- 8mg Sublingual Tablet as per Protocol
